Clinical Trials Browser

NCT07581834 2026-05-12

Efficacy and Safety of Dalpiciclib Combined With Endocrine Adjuvant Therapy for Early HR +/HER2- Breast Cancer: a Multicenter, Prospective Clinical Study

Phase 2 Recruiting

2,000 enrolled

Breast

Breast Diseases, Breast Neoplasms

NCT06335069 2025-09-24

18F-FDG Versus 68Ga-FAPI-46 as PET Tracer in ER-positive Breast Cancer.

Phase 2 Recruiting

20 enrolled

Breast

Breast Diseases, Breast Neoplasms

NCT04605575 2022-04-26

Pyrotinib Plus Vinorelbine in Participants With HER2-positive Previously Treated Locally Advanced or Metastatic Breast Cancer

Phase 2 Unknown

208 enrolled

Breast

Breast Diseases, Breast Neoplasms

NCT01499160 2022-02-11

Letrozole and Lapatinib Followed by Everolimus in Women With Advanced Breast Cancer

Phase 2 Terminated

7 enrolled 6 charts

Breast

Breast Diseases, Breast Neoplasms, Neoplasm Metastasis

NCT04088110 2019-09-12

Pyrotinib Combined With Trastuzumab Plus Aromatase Inhibitor in Treatment of Breast Cancer

Phase 2 Unknown

77 enrolled

Breast

Breast Diseases, Breast Neoplasms

NCT03910712 2019-04-10

Pyrotinib

Phase 2 Unknown

250 enrolled

Breast

Breast Diseases, Breast Neoplasms

NCT01472146 2017-05-09

ZoNantax - Zolendronic Acid as Neoadjuvant Therapy Plus Anthracycline and Taxane in Locally Advanced Breast Cancer

Phase 2 Completed

58 enrolled

Breast

Breast Diseases, Breast Neoplasms, Neoplasms, Neoplasms by Site

NCT00678626 2015-05-04

Phase 2 Trial Of CP-751,871 And Docetaxel In Advanced Breast Cancer

Phase 2 Withdrawn

Breast

Breast Diseases, Breast Neoplasms

NCT00050427 2011-04-28

A Study of ET-743 (Trabectedin) in Patients With Advanced Breast Cancer

Phase 2 Completed

53 enrolled

Breast

Breast Diseases, Breast Neoplasms, Neoplasms, Neoplasms by Site, Skin Diseases

NCT01043913 2010-01-07

Guarana (Paullinia Cupana) for Breast Cancer Chemotherapy-related Fatigue

Phase 2 Completed

60 enrolled

Breast

Breast Diseases, Breast Neoplasms, Fatigue, Neoplasms, Neoplasms by Site, Signs and Symptoms